Real-World Cladribine Study Shows Low Relapse Rates in Older Multiple Sclerosis
A multicenter observational study of older adults with relapsing multiple sclerosis treated with cladribine tablets documented low relapse rates and ...
A multicenter observational study of older adults with relapsing multiple sclerosis treated with cladribine tablets documented low relapse rates and ...
A large MSBase registry study found disease-modifying therapies for relapsing multiple sclerosis were associated with age-dependent reductions in disability progression, ...
A Danish nationwide registry study found lower short-term relapse rates and few confirmed disability-worsening events among people with relapsing–remitting multiple ...
Researchers converted serial cognitive reaction time data into images and used a Transformer-based deep survival model to predict disability progression ...
A Swedish study of 2,117 people with multiple sclerosis found that obesity at diagnosis accelerates long-term disability progression almost exclusively ...
A large Italian registry study finds no significant differences among four first-line multiple sclerosis therapies in protecting against relapse-independent disability ...
A nationwide Swedish cohort study of 3,094 people with multiple sclerosis found that having a first- or second-degree relative with ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine